EUVIMEDEUVIMED entdecken
Vergleichsstudie

Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT

Juan Montoro iD, Dirk-Jan Eikema, Joe Tuffnell, Victoria Potter, Krzysztof Kalwak iD, Constantijn J M Halkes iD, Alexander Kulagin iD, Matthew Collin iD, Robert F Wynn, Stephen Robinson, Emma Nicholson iD, Henrik Sengeloev iD und 15 weitere

Blood · 2024

DOI: 10.1182/blood.2024024173 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Blood, 2024. Verfasst von Juan Montoro und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Valencia, Spain. Hauptthemen laut MEDLINE: Anemia, Aplastic, Unrelated Donors, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Selecting the most suitable alternative donor becomes challenging in severe aplastic anemia (SAA) when a matched sibling donor (MSD) is unavailable. We compared outcomes in patients with SAA undergoing stem cell transplantation (SCT) from matched unrelated donors (MUD) (n = 1106), mismatched unrelated donors (MMUD) (n = 340), and haploidentical donors (Haplo) (n = 206) registered in the European Society for Blood and Marrow Transplantation database (2012-2021). For Haplo SCT, only those receiving posttransplant cyclophosphamide for graft-versus-host disease (GVHD) prophylaxis were included. Median age was 20 years, and the median time from diagnosis to transplantation 8.7 months. Compared with MUD, MMUD (hazard ratio [HR], 2.93; 95% confidence interval [CI], 1.52-5.6) and Haplo (HR, 5.15; 95% CI, 2.5-10.58) showed significantly higher risks of primary graft failure. MUD had lower rates of acute GVHD compared with MMUD and Haplo (grade 2-4: 13%, 22%, and 19%, respectively; P < .001; grade 3-4: 5%, 9%, and 7%, respectively; P = .028). The 3-year nonrelapse mortality rate was 14% for MUD, 19% for MMUD, and 27% for Haplo (P < .001), whereas overall survival and GVHD and relapse-free survival (GRFS) rates were 81% and 73% for MUD, 74% and 65% for MMUD, and 63% and 54% for Haplo, respectively (P < .001). In addition to donor type, multivariable analysis identified other factors associated with GRFS such as patient age, performance status, and interval between diagnosis and transplantation. For patients with SAA lacking an MSD, our findings support MUDs as the preferable alternative donor option. However, selecting between an MMUD and Haplo donor remains uncertain and requires further exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, AplasticUnrelated DonorsGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansFemaleMaleAdultAdolescentMiddle AgedYoung AdultChildChild, PreschoolTransplantation, HaploidenticalTissue Donors

Autor:innen und Institutionen

  • Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Valencia, Spain.
  • Universidad Católica de Valencia, Valencia, Spain.
  • EBMT Leiden Study Unit, Leiden, The Netherlands.
  • Department of Haematological Medicine, Kings College Hospital, London, United Kingdom.
  • Fundacja Na Ratunek Dzieciom z Choroba Nowotworowa, Wroclaw, Poland.
  • Leiden University Hospital, Leiden, The Netherlands.

ORCID-Profile: Juan Montoro, Krzysztof Kalwak, Constantijn J M Halkes, Alexander Kulagin, Matthew Collin, Emma Nicholson, Henrik Sengeloev, Elena Skorobogatova, Jaime Sanz, Jakob Passweg, Stephan Mielke, Samppa Ryhänen, Ben Carpenter, Tobias Gedde-Dahl, Austin Kulasekararaj, Antonio Risitano

Zitieren

APA

Montoro, J., Eikema, D. J., Tuffnell, J., Potter, V., Kalwak, K., Halkes, C. J. M., Kulagin, A., Collin, M., Wynn, R. F., Robinson, S., Nicholson, E., Sengeloev, H., Clay, J., Halahleh, K., Skorobogatova, E., Sanz, J., Passweg, J., Mielke, S., Ryhänen, S., …, & Peffault de Latour, R. (2024). Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT. Blood. https://doi.org/10.1182/blood.2024024173

Vancouver

Montoro J, Eikema DJ, Tuffnell J, Potter V, Kalwak K, Halkes CJM, et al. Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT. Blood. 2024. doi:10.1182/blood.2024024173

BibTeX
@article{Montoro2024,
  author = {Montoro, Juan and Eikema, Dirk-Jan and Tuffnell, Joe and Potter, Victoria and Kalwak, Krzysztof and Halkes, Constantijn J M and Kulagin, Alexander and Collin, Matthew and Wynn, Robert F and Robinson, Stephen and Nicholson, Emma and Sengeloev, Henrik and Clay, Jennifer and Halahleh, Khalid and Skorobogatova, Elena and Sanz, Jaime and Passweg, Jakob and Mielke, Stephan and Ryhänen, Samppa and Carpenter, Ben and Gedde-Dahl, Tobias and Tholouli, Eleni and Fanin, Renato and Lewalle, Philippe and Kulasekararaj, Austin and Risitano, Antonio and Peffault de Latour, Régis},
  title = {Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT},
  journal = {Blood},
  year = {2024},
  doi = {10.1182/blood.2024024173}
}
Kostenlos starten →